Saturday, November 1, 2014

Proliferation of Rogue Online Drug Sellers Feeds Prescription Drug Abuse Epidemic, NABP Reports


 Topics: Counterfeit Drugs and Buying Medicine Online
The National Association of Boards of Pharmacy® (NABP®) today issued a report highlighting a connection between the proliferation of rogue online drug sellers and the prescription drug abuse epidemic.
Read More →

Bulk Drug Substances That May Be Used to Compound Drug Products in Accordance With Section 503A of the Federal Food, Drug, and Cosmetic Act; Request for Nominations--FDA DocketID: FDA-2013-N-1525

view all 213 comments received:

here

IACP's comments Docket ID: FDA-2013-N-1525 Bulk Drug Substances That May Be Used to Compound Drug Products in Accordance With Section 503A of the Federal Food, Drug, and Cosmetic Act; Request for Nominations

 
  • Thank you for the opportunity to submit our comments on FDA’s request for a list of bulk drug substances that may be used in pharmacy compounding as defined within Section 503A of...
  • Public Submission
     
  • Posted:
     
    08/11/2014
     
  • ID:
     FDA-2013-N-1525-0107

Third Question of the Day November 1, 2014 Are there any compounding pharmacies that verify Certificates of Analyses (CoA) data with further testing? If so, is the testing for all parameters and results listed on the CoA's? If no verification is done and there is no warranty, isn't this problematic because of grey markets, counterfeit and substandard bulks that threaten the supply chain?

Second Question of the Day November 1, 2014 Does anyone know of any repackager that provides warranty for results stated on CoAs for API or Bulk Chemicals?